Bereich
Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen
ENDO · Dept. I
Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index
Ruge T, Lockton J, Renström F, Lystig T, Sukonina V, Svensson M, Eriksson J. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metab Clin Exp 2009; 58:860-6.
01.06.2009Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index
01.06.2009Metab Clin Exp 2009; 58:860-6
Ruge Toralph, Lockton J Andrew, Renström Frida, Lystig Theodore, Sukonina Valentina, Svensson Maria K, Eriksson Jan W
New onset alopecia and hirsutism in a postmenopausal women
Bühler-Christen A, Tischler V, Diener P, Brändle M. New onset alopecia and hirsutism in a postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009; 25:324-7.
01.05.2009New onset alopecia and hirsutism in a postmenopausal women
01.05.2009Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009; 25:324-7
Bühler-Christen Annette, Tischler Verena, Diener Pierre-André, Brändle Michael
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults
Jonsson A, Renström F, Lyssenko V, Brito E, Isomaa B, Berglund G, Nilsson P, Groop L, Franks P. Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia 2009; 52:1334-8.
17.04.2009Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults
17.04.2009Diabetologia 2009; 52:1334-8
Jonsson A, Renström Frida, Lyssenko V, Brito E C, Isomaa B, Berglund G, Nilsson P M, Groop L, Franks P W
Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults
Brito E, Lyssenko V, Renström F, Berglund G, Nilsson P, Groop L, Franks P. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. Diabetes 2009; 58:1411-8.
26.03.2009Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults
26.03.2009Diabetes 2009; 58:1411-8
Brito Ema C, Lyssenko Valeriya, Renström Frida, Berglund Göran, Nilsson Peter M, Groop Leif, Franks Paul W
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
Brändle M, Goodall G, Erny-Albrecht K, Erdmann E, Valentine W. Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:173-84.
21.03.2009Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
21.03.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:173-84
Brändle Michael, Goodall G, Erny-Albrecht K M, Erdmann E, Valentine W J
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
Marre M, Colagiuri S, Le Thi T, Zdravkovic M, Strand J, Kamaruddin N, Bebakar W, Brändle M, Shaw J, LEAD-1 SU study group. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic medicine : a journal of the British Diabetic Association 2009; 26:268-78.
01.03.2009Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
01.03.2009Diabetic medicine : a journal of the British Diabetic Association 2009; 26:268-78
Marre M, Colagiuri S, Le Thi T D, Zdravkovic M, Strand J, Kamaruddin N A, Bebakar W M W, Brändle Michael, Shaw J, LEAD-1 SU study group
Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease
Sutter R, Killer H, Bilz S, Baumgartner M, Ott H, Steck A, Renaud S. Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:e45-6.
01.03.2009Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease
01.03.2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:e45-6
Sutter R, Killer H E, Bilz Stefan, Baumgartner M, Ott H W, Steck A J, Renaud S
Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus
Phillippe J, Weissenberger B, Stahl M, Ruiz J, Kuntschen F, Keller U, Diem P, Carrel J, Brändle M, Spinas G. Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus - Consensus Statement der Schweizerischen Gesellschaft für Endokrinologie. Swiss Medical Forum 2009; 9:50-55.
22.01.2009Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus
22.01.2009Swiss Medical Forum 2009; 9:50-55
Phillippe Jacques, Weissenberger Benno, Stahl Matthias, Ruiz Juan, Kuntschen François, Keller Ulrich, Diem Peter, Carrel Jacques, Brändle Michael, Spinas Giatgen A
Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden
Renström F, Franks P, Nordström P, Barroso I, Hallmans G, Rolandsson O, Brito E, Nordström A, Payne F. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet 2009; 18:1489-96.
22.01.2009Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden
22.01.2009Hum Mol Genet 2009; 18:1489-96
Renström Frida, Franks Paul W, Nordström Peter, Barroso Inês, Hallmans Göran, Rolandsson Olov, Brito Ema C, Nordström Anna, Payne Felicity
Nicht verzagen, den Pathologen fragen
Krull I. Nicht verzagen, den Pathologen fragen. Swiss Medical Forum 2009; 9:779-781.
21.01.2009Nicht verzagen, den Pathologen fragen
21.01.2009Swiss Medical Forum 2009; 9:779-781
Krull Ina
Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study
Schimke K, Chubb S, Davis W, Phillips P, Davis T. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Diabetic medicine : a journal of the British Diabetic Association 2009; 26:70-5.
01.01.2009Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study
01.01.2009Diabetic medicine : a journal of the British Diabetic Association 2009; 26:70-5
Schimke Katrin-Elisabeth, Chubb S A P, Davis W A, Phillips P, Davis T M E
AZ-Verschlechterung unter Gemcitabine
Wille T. AZ-Verschlechterung unter Gemcitabine. Swiss Medical Forum 2008; 8:855-856.
24.10.2008AZ-Verschlechterung unter Gemcitabine
24.10.2008Swiss Medical Forum 2008; 8:855-856
Wille Tonio
Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle
Morino K, Philbrick W, White M, Sebastian D, Samuel V, Nagai Y, Moore I, Reznick R, Tsirigotis D, Sono S, Bilz S, Neschen S, Shulman G. Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 2008; 57:2644-51.
01.10.2008Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle
01.10.2008Diabetes 2008; 57:2644-51
Morino Katsutaro, Philbrick William, White Morris, Sebastian David, Samuel Varman, Nagai Yoshio, Moore Irene, Reznick Richard M, Tsirigotis Dimitrios, Sono Saki, Bilz Stefan, Neschen Susanne, Shulman Gerald I
Seizures, hyponatraemia, and "poison"
Drescher T, Klima T, Schifferli J. Seizures, hyponatraemia, and "poison". Lancet 2008; 371:2144.
21.06.2008Seizures, hyponatraemia, and "poison"
21.06.2008Lancet 2008; 371:2144
Drescher Tilman, Klima Theresia, Schifferli Jürg
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
Templeton A, Brändle M, Cerny T, Gillessen Sommer S. Remission of diabetes while on sunitinib treatment for renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5.
01.04.2008Remission of diabetes while on sunitinib treatment for renal cell carcinoma
01.04.2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5
Templeton Arnoud, Brändle Michael, Cerny Thomas, Gillessen Sommer Silke
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
Strasser F, Cerny T, Von Moss R, Brändle M, Holst B, Kaufmann K, Tschöp M, Büche D, Thürlimann B, Maeder M, Lutz T, Demmer-Steingruber R. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. BJC 2008; 98:300-8.
29.01.2008Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
29.01.2008BJC 2008; 98:300-8
Strasser Florian, Cerny Thomas, Von Moss Roger, Brändle Michael, Holst B, Kaufmann K, Tschöp M, Büche Daniel, Thürlimann Beat, Maeder Micha, Lutz T A, Demmer-Steingruber Ruth
Back pain from a burger
Drescher T, Potthast S, Laifer G. Back pain from a burger. Lancet 2008; 371:358.
26.01.2008Back pain from a burger
26.01.2008Lancet 2008; 371:358
Drescher Tilman, Potthast Silke, Laifer Gerd
[19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)]
Lipowsky C, Schorl-Schweikardt B, Kehl O, Brändle M. [19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)]. Praxis 2008; 97:77-81.
23.01.2008[19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)]
23.01.2008Praxis 2008; 97:77-81
Lipowsky Christof, Schorl-Schweikardt B A, Kehl Oth, Brändle Michael
[Hypertension and hyperhidrosis. Pheochromocytoma]
Mettler J, Battegay E, Egelhof T, Oertli D, Zimmerli L, Bilz S. [Hypertension and hyperhidrosis. Pheochromocytoma]. Praxis 2008; 97:73-6.
23.01.2008[Hypertension and hyperhidrosis. Pheochromocytoma]
23.01.2008Praxis 2008; 97:73-6
Mettler J, Battegay E, Egelhof T, Oertli D, Zimmerli L, Bilz Stefan
Cost analysis of diabetes and pregnancy
Brändle M. Cost analysis of diabetes and pregnancy. In: Textbook of Diabetes and Pregnancy. 2nd EditionLondon, England: Informa Health Care, 2008. ISBN 978 0 415 42620 6. S. 392-398.
01.01.2008Cost analysis of diabetes and pregnancy
01.01.2008Informa Health Care, ISBN 978 0 415 42620 6
Brändle Michael